ABOUT TRANSPHARMATION LTD.
Transpharmation is led by a team with years of proven hands-on drug discovery and business expertise. This has allowed us to build client and science-focused relationships, across our extensive network in the pharmaceutical and biotechnology sectors.
Our mission is simple; we wish to be known as the market leader in the provision of innovation and science-led translational biology. We believe, we have made significant steps to achieving this goal and invite you to explore our website to further understand how our strategy can enhance your Drug Discovery programmes.
A CRO should offer technologies you do not have in your own company. Investment in technology, bringing capabilities together, underpins our desire to innovate & produce multiple endpoints to a single study.
We are constantly looking for novel preclinical/clinical assays, technologies and endpoints that increase your success. Wherever possible we strive to publish our research in peer reviewed journals.
KEY FINANCES
Year
2016
Assets
£907.51k
▲ £277.15k (43.97 %)
Cash
£420.35k
▲ £240.22k (133.36 %)
Liabilities
£141.12k
▲ £11.77k (9.10 %)
Net Worth
£766.39k
▲ £265.38k (52.97 %)
REGISTRATION INFO
-
Check the company
-
UK
-
Camden
- Company name
- TRANSPHARMATION LTD.
- Company number
- 07348226
- Status
-
Active
- Categroy
- Private Limited Company
- Date of Incorporation
-
17 Aug 2010
Age - 14 years
- Home Country
- United Kingdom
CONTACTS
- Website
- www.transpharmation.co.uk
- Phones
-
+44 (0)2076 910 984
02076 910 984
- Registered Address
- THE LONDON BIOSCIENCE INNOVATION CENTRE,
2 ROYAL COLLEGE STREET,
LONDON,
NW1 0NH
ECONOMIC ACTIVITIES
- 74909
- Other professional, scientific and technical activities n.e.c.
LAST EVENTS
- 17 Oct 2016
- Appointment of Susan Upton as a director on 17 October 2016
- 17 Oct 2016
- Appointment of Karen Melissa Lawrence as a director on 17 October 2016
- 30 Sep 2016
- Total exemption small company accounts made up to 31 December 2015
See Also
Last update 2018
TRANSPHARMATION LTD. DIRECTORS
Duxon Mark Steven Dr
Acting
- Appointed
- 23 January 2012
- Occupation
- Consultant
- Role
- Director
- Age
- 53
- Nationality
- British
- Address
- The London Bioscience Innovation Centre, 2 Royal College Street, London, United Kingdom, NW1 0NH
- Country Of Residence
- United Kingdom
- Name
- DUXON, Mark Steven, Dr
Karen Melissa Lawrence
Acting
- Appointed
- 17 October 2016
- Occupation
- Home Maker
- Role
- Director
- Age
- 53
- Nationality
- British
- Address
- The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
- Country Of Residence
- England
- Name
- LAWRENCE, Karen Melissa
Upton Neil Dr
Acting
- Appointed
- 17 August 2010
- Occupation
- Research Scientist
- Role
- Director
- Age
- 67
- Nationality
- British
- Address
- The London Bioscience Innovation Centre, 2 Royal College Street, London, United Kingdom, NW1 0NH
- Country Of Residence
- England
- Name
- UPTON, Neil, Dr
Susan Upton
Acting
- Appointed
- 17 October 2016
- Occupation
- Director Of Corporate Services
- Role
- Director
- Age
- 67
- Nationality
- British
- Address
- The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
- Country Of Residence
- England
- Name
- UPTON, Susan
Karen Melissa Lawrence
Resigned
- Appointed
- 17 August 2010
- Resigned
- 23 January 2012
- Occupation
- None
- Role
- Director
- Age
- 53
- Nationality
- British
- Address
- The London Bioscience Innovation Centre, 2 Royal College Street, London, United Kingdom, NW1 0NH
- Country Of Residence
- United Kingdom
- Name
- LAWRENCE, Karen Melissa
REVIEWS
Check The Company
Excellent according to the company’s financial health.
